此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Wearable Sleep EEG and Auditory Stimulation in Healthy Adults

2026年9月1日 更新者:Ali Yousefi、University of Houston

Evaluation of a Wearable Sleep Monitoring Platform With Acoustic Stimulation for Mood Regulation

The purpose of this single-site pilot study is to evaluate the feasibility, usability, and technical performance of a wearable sleep-monitoring system that records electroencephalography (EEG) and delivers brief, low-volume sounds during selected stages of sleep.

Approximately 30 healthy adults aged 18 to 30 years will use the system at home for up to 12 weeks, with a target of at least 15 usable nights of sleep recording. Participants will also complete smartphone-based assessments of sleep, mood, stress, device experience, and memory.

The study will evaluate home-use completion, EEG signal quality, automated sleep-stage detection, delivery of auditory stimulation, participant adherence, and safety and tolerability. This pilot study is intended to refine the device and study procedures and is not designed to determine whether the system treats depression or another medical condition.

研究概览

详细说明

Participants will complete eligibility screening and provide written informed consent before beginning study procedures. At enrollment, University of Houston study personnel will provide training on placement and removal of the forehead sensor, use of the study smartphone and application, device handling and charging, reporting of discomfort or technical problems, and procedures for stopping device use.

Participants will use the wearable EEG-based sleep-monitoring system at home during natural sleep for up to 12 weeks, with a target of at least 15 usable nights of sleep data. The external, battery-powered, non-invasive system records EEG and device-session information, supports automated sleep-stage detection, and delivers brief, low-volume pink-noise sounds during selected stages of non-rapid eye movement sleep according to study-configured closed-loop timing parameters. The device does not deliver electrical stimulation to the participant. Device and auditory-stimulation settings will be configured by study personnel and will not be adjusted by participants.

During the home-use period, participants will complete smartphone-based assessments that include sleep-diary information, sleep quality, mood, stress, device feedback, and memory tasks. Study personnel will provide technical assistance and monitor device use, data quality, participant-reported discomfort, and device or application problems.

Study analyses will focus on home-use feasibility, completion of usable recording nights, participant adherence, EEG signal quality, automated sleep-stage classification, slow-wave activity, delta sleep ratio, auditory-stimulation timing and delivery performance, application completion, and safety and tolerability. Findings will be used to refine the wearable system, signal-processing algorithms, participant instructions, and study procedures before a later clinical assessment in adults with major depressive disorder.

研究类型

介入性

注册 (估计的)

30

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人

接受健康志愿者

是的

描述

Inclusion Criteria:

  • Age 18-30 years.
  • Able to provide independent written informed consent.
  • Able to read and speak English.
  • Generally healthy and maintains a regular sleep schedule.
  • Willing and able to use the wearable EEG system at home during sleep and complete smartphone-based assessments.
  • Adequate hearing to perceive the auditory stimulation.
  • Able to follow device-use, safety-reporting, and study procedures.

Exclusion Criteria:

  • Diagnosed sleep disorder, including insomnia or sleep apnea.
  • Diagnosed psychiatric condition, including major depressive disorder or an anxiety disorder.
  • Neurological disorder, including epilepsy, seizure disorder, or significant traumatic brain injury.
  • Hearing impairment that would interfere with auditory stimulation.
  • Use of medication expected to substantially affect sleep, mood, or study outcomes, including sedative-hypnotic or relevant psychoactive medication.
  • Known allergy or sensitivity to device materials, adhesives, conductive materials, or other skin-contact components.
  • Current pregnancy.
  • Cognitive impairment or another condition preventing independent consent. Prisoner status.
  • Student or employee over whom the investigator or study personnel have direct grading, supervisory, employment, or evaluative authority.
  • Acute illness, dizziness, significant headache or earache, excessive fatigue, or another temporary safety or data-quality concern at the time of study procedures. Participation may be deferred or rescheduled when appropriate.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:其他
  • 分配:不适用
  • 介入模型:单组作业
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Wearable EEG Monitoring and Closed-Loop Auditory Stimulation
Participants will use the investigational wearable EEG-based sleep-monitoring system at home during sleep for up to 12 weeks, targeting at least 15 usable nights of recording. The system records sleep EEG and device-session information and delivers brief, low-volume auditory stimulation according to study-configured closed-loop timing parameters. Participants will also complete smartphone-based sleep, mood, stress, device-feedback, and memory assessments.
An investigational, external, battery-powered, non-invasive forehead-worn system that records EEG during sleep, supports automated sleep-stage and slow-wave detection, and delivers brief, low-volume pink-noise sounds during selected stages of non-rapid eye movement sleep according to study-configured closed-loop timing parameters. The system does not deliver electrical stimulation to the participant. Device and stimulation settings are configured by study personnel.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Proportion of Participants Completing at Least 15 Usable Home Sleep-Recording Nights
大体时间:From initiation of home use through the end of the home-use period, up to 12 weeks
Number of participants completing at least 15 usable nights divided by the number of enrolled participants who initiate home use. A usable night contains sufficient continuous wearable EEG and device-log data for the planned signal-processing and algorithmic stimulation-delivery analyses. The prespecified feasibility benchmark is greater than 75%.
From initiation of home use through the end of the home-use period, up to 12 weeks

次要结果测量

结果测量
措施说明
大体时间
Automated Sleep-Stage Classification Accuracy
大体时间:During home device use, up to 12 weeks
Percentage of sleep epochs correctly classified against reference labels, with balanced accuracy, sensitivity, specificity, precision, recall, F1 score, and Cohen's kappa also reported.
During home device use, up to 12 weeks
Closed-Loop Auditory Stimulation Delivery Success Rate
大体时间:During home device use, up to 12 weeks
Percentage of algorithm-triggered auditory pulses successfully delivered and recorded within prespecified timing and latency limits. Device logs will also characterize missed events and alignment with targeted sleep-stage or slow-wave features.
During home device use, up to 12 weeks
Number of Attempted Wearable-Device Nights per Participant
大体时间:From enrollment through the end of home use, up to 12 weeks
Number of nights on which each participant attempts wearable-device use, regardless of whether the resulting recording meets the usable-night criteria.
From enrollment through the end of home use, up to 12 weeks
Smartphone Assessment Completion Rate
大体时间:From enrollment through the end of home use, up to 12 weeks
Percentage of scheduled smartphone-based sleep diary, sleep-quality, mood, stress, device-feedback, and study-task assessments completed by each participant during the home-use period.
From enrollment through the end of home use, up to 12 weeks
Number of Participants With Device- or Procedure-Related Adverse Events
大体时间:From first device use through study exit, up to 12 weeks
Number and percentage of participants with device- or procedure-related adverse events, including skin irritation, discomfort, sleep disruption, device malfunction, or app problems.
From first device use through study exit, up to 12 weeks
Percentage of Recorded Sleep Epochs Meeting EEG Signal-Quality Criteria
大体时间:During home device use, up to 12 weeks
Percentage of recorded sleep epochs meeting the prespecified signal-quality, signal-to-noise, and artifact-rejection criteria required for automated sleep-stage classification and estimation of slow-wave activity and delta sleep ratio.
During home device use, up to 12 weeks

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Ali Yousefi, Ph.D.、University of Houston, Houston, TX, United States

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2027年4月1日

初级完成 (估计的)

2028年6月30日

研究完成 (估计的)

2028年6月30日

研究注册日期

首次提交

2026年8月29日

首先提交符合 QC 标准的

2026年9月1日

首次发布 (实际的)

2026年9月9日

研究记录更新

最后更新发布 (实际的)

2026年9月9日

上次提交的符合 QC 标准的更新

2026年9月1日

最后验证

2026年9月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

是的

IPD 计划说明

De-identified individual participant data underlying the reported study results may be shared with qualified researchers, consistent with participant consent and subject to applicable IRB, institutional, data-use, and privacy requirements. Direct identifiers and the participant-code linkage file will not be shared.

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

是的

在美国制造并从美国出口的产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅